Search research articles
Contact Us
Filters
Showing results (11-20 of 87) with videos related to
Page
of 9
Sort By:
Journal of Medical Genetics
|
October 17, 2018
De novo pathogenic variants in neuronal differentiation factor 2 (NEUROD2) cause a form of early infantile epileptic encephalopathy
Annalisa G Sega, Emily K Mis, Kristin Lindstrom, et al.
Journal of Genetic Counseling
|
September 24, 2020
Advancing the genetic counseling profession through research: Identification of priorities by the National Society of Genetic Counselors research task force
Leigha Senter, Jehannine C Austin, Meghan Carey, et al.
Neurogenetics
|
August 5, 2015
Mutations in ARID2 are associated with intellectual disabilities
Linshan Shang, Megan T Cho, Kyle Retterer, et al.
American Journal of Medical Genetics. Part A
|
September 24, 2017
Loss-of-function variants in NFIA provide further support that NFIA is a critical gene in 1p32-p31 deletion syndrome: A four patient series
Anya Revah-Politi, Mythily Ganapathi, Louise Bier, et al.
American Journal of Medical Genetics. Part A
|
July 29, 2018
De novo missense variants in MEIS2 recapitulate the microdeletion phenotype of cardiac and palate abnormalities, developmental delay, intellectual disability and dysmorphic features
Ganka Douglas, Megan T Cho, Aida Telegrafi, et al.
Cold Spring Harbor Molecular Case Studies
|
May 6, 2016
De novo mutations in PURA are associated with hypotonia and developmental delay
Akemi J Tanaka, Renkui Bai, Megan T Cho, et al.
Journal of Medical Genetics
|
July 18, 2015
Mutations in COQ4, an essential component of coenzyme Q biosynthesis, cause lethal neonatal mitochondrial encephalomyopathy
Wendy K Chung, Kimberly Martin, Chaim Jalas, et al.
Neurogenetics
|
April 21, 2016
A recurrent de novo CTBP1 mutation is associated with developmental delay, hypotonia, ataxia, and tooth enamel defects
David B Beck, Megan T Cho, Francisca Millan, et al.
Cold Spring Harbor Molecular Case Studies
|
May 6, 2016
De novo pathogenic variants in CHAMP1 are associated with global developmental delay, intellectual disability, and dysmorphic facial features
Akemi J Tanaka, Megan T Cho, Kyle Retterer, et al.
Cold Spring Harbor Molecular Case Studies
|
May 6, 2016
De novo POGZ mutations are associated with neurodevelopmental disorders and microcephaly
Yizhou Ye, Megan T Cho, Kyle Retterer, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 87) with videos related to
Sort By:
Page
of 9
Journal of Medical Genetics
|
October 17, 2018
De novo pathogenic variants in neuronal differentiation factor 2 (NEUROD2) cause a form of early infantile epileptic encephalopathy
Annalisa G Sega, Emily K Mis, Kristin Lindstrom, et al.
Journal of Genetic Counseling
|
September 24, 2020
Advancing the genetic counseling profession through research: Identification of priorities by the National Society of Genetic Counselors research task force
Leigha Senter, Jehannine C Austin, Meghan Carey, et al.
Neurogenetics
|
August 5, 2015
Mutations in ARID2 are associated with intellectual disabilities
Linshan Shang, Megan T Cho, Kyle Retterer, et al.
American Journal of Medical Genetics. Part A
|
September 24, 2017
Loss-of-function variants in NFIA provide further support that NFIA is a critical gene in 1p32-p31 deletion syndrome: A four patient series
Anya Revah-Politi, Mythily Ganapathi, Louise Bier, et al.
American Journal of Medical Genetics. Part A
|
July 29, 2018
De novo missense variants in MEIS2 recapitulate the microdeletion phenotype of cardiac and palate abnormalities, developmental delay, intellectual disability and dysmorphic features
Ganka Douglas, Megan T Cho, Aida Telegrafi, et al.
Cold Spring Harbor Molecular Case Studies
|
May 6, 2016
De novo mutations in PURA are associated with hypotonia and developmental delay
Akemi J Tanaka, Renkui Bai, Megan T Cho, et al.
Journal of Medical Genetics
|
July 18, 2015
Mutations in COQ4, an essential component of coenzyme Q biosynthesis, cause lethal neonatal mitochondrial encephalomyopathy
Wendy K Chung, Kimberly Martin, Chaim Jalas, et al.
Neurogenetics
|
April 21, 2016
A recurrent de novo CTBP1 mutation is associated with developmental delay, hypotonia, ataxia, and tooth enamel defects
David B Beck, Megan T Cho, Francisca Millan, et al.
Cold Spring Harbor Molecular Case Studies
|
May 6, 2016
De novo pathogenic variants in CHAMP1 are associated with global developmental delay, intellectual disability, and dysmorphic facial features
Akemi J Tanaka, Megan T Cho, Kyle Retterer, et al.
Cold Spring Harbor Molecular Case Studies
|
May 6, 2016
De novo POGZ mutations are associated with neurodevelopmental disorders and microcephaly
Yizhou Ye, Megan T Cho, Kyle Retterer, et al.
Page
of 9